New qualifying conditions approved by the New Jersey Medicinal Marijuana Review Panel.
Patients with chronic pain, anxiety, and migraines will have to wait a little longer to participate in the NJ medical marijuana program. The New Jersey Medicinal Marijuana Review Panel (MMRP) recently voted to approve several new qualifying conditions, but the Department of Public Health now has 180 days to render a final decision.
Adding New Qualifying Conditions to New Jersey’s Medicinal Marijuana Program
New Jersey’s medical marijuana program is one of the strictest in the country. To participate in the program, a patient must suffer from an approved debilitating medical condition. The current list of qualifying conditions for medical marijuana includes, among others, amyotrophic lateral sclerosis (Lou Gehrig’s disease), Multiple Sclerosis, terminal cancer, muscular dystrophy, inflammatory bowel disease, certain terminal illnesses, and post-traumatic stress disorder.
The process of adding new qualifying conditions is lengthy and complex. Pursuant to N.J.A.C. 8:64-5.2, the inclusion of new qualifying condition must be approved by the MMRP and the Commissioner. When making a recommendation, the primary consideration is whether the medical condition and/or the treatment thereof is debilitating; and whether marijuana is more likely than not to have the potential to be beneficial to treat or alleviate the debilitation associated with the medical condition and/or the treatment thereof.
Almost four months ago, the MMRP recommended that the Commissioner qualify dozens of additional debilitating conditions falling within the categories of chronic pain, migraine, anxiety, and Tourette’s Syndrome for inclusion in the State’s medicinal marijuana program. The MMRP rejected the inclusion of conditions related to the categories of asthma and chronic fatigue.
What’s Next for Medical Marijuana Patients?
The 60-day public comment period on the MMRP’s recommendations ended on September 25, 2017. On October 25, 2017, the panel voted 5-1 to grant final approval of the new conditions. It again voted unanimously to deny the addition of asthma and chronic fatigue syndrome.
Now, Health Commissioner Cathleen Bennett has up to six months to decide whether to approve the panel’s recommendation. The final hurdle is significant given that Bennett, a who was appointed by Gov. Chris Christie, has opposed cannabis legalization in the past.
However, given that the deadline will occur after the New Jersey gubernatorial election, Bennett may no longer be in the post at that time. In addition, if Phil Murphy is the next governor, an even broader expansion of the NJ medical marijuana program could be on the horizon.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
When to Settle and When to Fight: A Litigator's Framework
Every lawsuit comes with a cost, and knowing when to settle a lawsuit is one of the most consequential decisions a business owner will face. Experienced litigators understand how to minimize cost and obtain certainty for their clients. For many business owners, the decision is viewed almost entirely through a financial lens: What will it cost […]
A Whistleblower Just Filed a Complaint Against Your Company: Here's What to Do Now
Few situations create more uncertainty than learning that an employee has filed a whistleblower complaint. Questions arise immediately: Is the allegation legitimate? Should the employee be placed on leave? Do we need to notify our insurance carrier? Are we now prevented from disciplining the employee if there are unrelated ongoing work related issues? There is […]
Assignment for the Benefit of Creditors: An Alternative to Bankruptcy for Distressed Businesses
When a business reaches the point where it can no longer service its debts or otherwise resolve its liabilities, management is often faced with a difficult question: is a bankruptcy filing necessary or is there another way to perform an orderly liquidation or sale of the business assets? While Chapters 7 and 11 of the […]
Breaking Down New Jersey’s “Mansion” Tax: What Buyers and Sellers Need to Know
For many years, the New Jersey Mansion Tax has been a significant consideration in high-value real estate transactions. Recent legislative changes, however, have substantially altered how the tax operates, including who is responsible for paying it and the amount owed in certain transactions. Whether you are purchasing, selling, or investing in New Jersey real estate, […]
Estate Planning for Digital Assets Under New Jersey Law
As our personal and financial lives increasingly move online, estate planning must evolve to address a new category of property: digital assets. From email accounts and social media profiles to cryptocurrency and cloud-stored business records, these assets often carry both financial and sentimental value. Yet, without proper planning, they can become inaccessible—or even lost—upon incapacity […]
The Role of Representation and Warranty Insurance in M&A Transactions
In today’s mergers and acquisitions market, representation and warranty (R&W) insurance has become a common feature of deal negotiations. Once used primarily in larger transactions, R&W insurance is now frequently incorporated into middle-market deals as buyers and sellers look for efficient ways to allocate risk and close deals. When structured properly, R&W insurance can help […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
